![](https://investorshub.advfn.com/uicon/529502.png?cb=1651683647)
Monday, August 15, 2022 11:51:29 AM
What is conveniently left out is that Lilly had absolutely NO INTEREST in what Regen found. Molecules that interact with a receptor isn't evidence that any of those molecules will do anything to cure anything.
And that's WHY Lilly showed ZERO interest in anything Regen had! Lilly might have told Deadbeat Dave, "prove that what you have regarding regulating NR2f6 and then we'll talk" but we all know that will never happen as Deadbeat Dave has no money to actually move forward with testing the receptor.
How's that for a really hard and inconvenient fact along with there won't be any buy out unless it is micro pennies on the penny! And I even doubt that will happen.
LOL ROFL PIMPL!!!
FACTS are stubborn things
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM